Highmark INC
Based in PA
AI Overview
With $8.8M in lobbying spend across 34 quarterly filings, Highmark INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $1.3M |
| 2019 | $1.3M |
| 2020 | $1.1M |
| 2021 | $1.5M |
| 2022 | $1.0M |
| 2023 | $980K |
| 2024 | $590K |
| 2025 | $1.1M |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Highmark INC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Medicare/Medicaid, Budget/Appropriations, Pharmacy and 1 more
Health Insurance Tax (HIT Tax); Tax Credits; Tax Reform; ACA Individual Mandate Penalty
H.R.1 - An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the bu
Affordable Care Act (ACA) Regulations; Health Care Reform; Reinsurance; CSRs (Cost Sharing Reductions); Individual Mandate; Drug Pricing; Individual Market Reform; Market Stabilization; AHPs (Associat
CHIP Funding/Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Medicare Advantage; Employer Group Waiver Plans; 2019 Medicare Advantage Part D Call Letter/Rate Notice; Medicaid Provi
CSRs; Reinsurance
H.R.1625 - Consolidated Appropriations Act of 2018
H.R. 1892 - Bipartisan Budget Act of 2018
Drug Pricing; Opioids
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.